Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia clinical trials

Explore recruiting ischemic stroke patients with secondary post rtpa hypofibrinogenemia clinical trials.

Also recruiting in Europe

Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia trials by city

Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Toronto Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Vancouver Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Montreal Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Calgary Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Edmonton Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Ottawa Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Winnipeg Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Quebec City Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Hamilton Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Kitchener Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in London Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Halifax Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in New York Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Los Angeles Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Chicago Ischemic Stroke Patients With Secondary Post Rtpa Hypofibrinogenemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease